Welcome to the e-CCO Library!

P298: Wall thickness ratio, a new magnetic resonance parameter, predicts the outcome of biological therapy in patients with ileal and ileocolonic Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Balestrieri*1, M. Ribolsi1, A. Tullio1, E. Solida1, A. Giordano1, M. Cicala1

Created: Friday, 22 February 2019, 9:41 AM
P299 A prospective randomised trial comparing dye-based chromoendoscopy with electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. González-Bernardo1,2, S. Vivas3, R. de Francisco1,4, I. Pérez-Martínez1,4, A. Castaño-García1,4, V. Jiménez-Beltrán1, P. Flórez-Díez1, S. Martínez-González4, V. Rolle5, P. Suárez5, A. Suárez1,4, S. Riestra Menéndez1,4

Created: Thursday, 30 January 2020, 10:12 AM
P299: A novel ileocolonic Crohn’s staging tool: the development and validation of an evidence-based, end-user informed radiological decision-aid
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. S. Morar*1,2, K. A. Wasmann3, A. C. T. Fareleira4, K. Sahnan1,2, S. O. Adegbola1,2, E. Mainta1, R. Ilangovan1, S. Arora2, N. Sevdalis5, K. Koysombat1, A. Hart1,2, D. Burling1, C. Edwards6, J. Warusavitarne1,2, A. Gupta1, W. A. Bemelman3, O. Faiz1,2

Created: Friday, 22 February 2019, 9:41 AM
P299: Disability in newly diagnosed patients with Crohn´s Disease: initial results from the prospective CROCO (Crohn´s Disease Cohort) Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tinoco da Silva TorresMD- PhD, J.(1,2)*;Ellul, P.(3);Vieujean, S.(4);Ordas, I.(5);Burisch, J.(6);Mocanu, I.(7);Duricova, D.(8);Rodríguez-Lago, I.(9);Buisson, A.(10);Goldis, A.(11);Hernandez, V.(12);Arebi, N.(13);Kaimakliotis, I.(14);Nachury, M.(15);Fumery, M.(16);Allocca, M.(17);Pedersen, N.(18);Barberio, B.(19);Shaji, S.(20);Guedes, A.(21);Ribeiro, R.(21);Ungaro, R.(22);Lambert, J.(23);Colombel, J.F.(22);
Created: Friday, 14 July 2023, 11:05 AM
P299: Identification of a prognostic biomarker able to predict ulcerative colitis patients that will not respond to standard therapy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pereira M.1, Carvalho S.1, Azevedo L.2, Albergaria A.1, Lima J.1, Reis C.3, Pedroto I.4, Maia L.4, Marcos-Pinto R.4, Lago P.4, Pinho S.S.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P299: Is quality of life different between Crohn’s disease patients submitted to early surgery or immunosuppression?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Barosa*, M. Patita, G. Nunes, C. Carreira, C. Cruz, C. Boal, A. I. Vieira, J. Freitas

Created: Friday, 22 February 2019, 9:49 AM
P299: Loss-of-response to anti-tumour necrosis factor-α critically depends on treatment duration in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Schultheiss, J.(1);Mahmoud, R.(1);Louwers, J.(1);van der Kaaij, M.(1);van Hellemondt, B.(1);van Boeckel, P.(2);Mahmmod, N.(2);Jharap, B.(3);Fidder, H.(1);Oldenburg, B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P299: Prediction model for steroid-free clinical remission with vedolizumab at week 22 in patients with Ulcerative Colitis: Machine learning using clinical data at baseline
Year: 2022
Source: ECCO'22
Authors: Miyoshi, J.(1);Maeda, T.(2);Matsuoka, K.(3);Saito, D.(1);Morikubo, H.(1);Matsuura, M.(1);Tamura, S.(2);Hisamatsu, T.(1);
Created: Friday, 11 February 2022, 3:52 PM
P299: Relation of body mass index and health outcomes in elderly patients with inflammatory bowel disease (IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Slagboom, V. Asscher*, L. Meijer, S. Waars, A. Van der Meulen- de Jong, J. Maljaars

Created: Thursday, 21 February 2019, 9:14 AM
P300 Colectomy and health-related quality life in children with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. DIPASQUALE1, M.A. Catena1, L. Paiano1, G. Trimarchi2, C. Romeo1, G. Navarra1, G. Mattioli3, C. Romano1

Created: Thursday, 30 January 2020, 10:12 AM
P300: Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. The STRIDENT Randomised Controlled Trial
Year: 2021
Source: ECCO'21 Virtual
Authors: Schulberg, J.(1,2);Wright, E.(1,2);Holt, B.(1,2);Sutherland, T.(2,3);Ross, A.(1);Hamilton, A.(1,2);Vogrin, S.(2);Miller, A.(1);Connell, W.(1);Lust, M.(1);Ding, N.(1,2);Moore, G.(4);Bell, S.(4);Shelton, E.(4);Christensen, B.(5);De Cruz, P.(6);Rong, Y.(7);Kamm, M.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P300: Illness perceptions and coping with health-related quality of life in patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cohen I.*1, Benyamini Y.2, Tulchinsky H.3, Dotan I.1

Created: Wednesday, 20 February 2019, 10:36 AM
P300: Long-term surgical outcomes following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis in a tertiary IBD centre in Brazil
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. S. Parra*1, M. R. Feitosa1, F. C. Pereira1, R. S. Rodrigues1, O. Féres1, J. J. Ribeiro da Rocha1

Created: Friday, 22 February 2019, 9:41 AM
P300: Overweight and obesity in Inflammatory Bowel disease: epidemiology, disease course and treatment outcomes
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Khemiri, W.(1)*;Ben Mustapha, N.(1);Ben Safta, N.(1);Serghini, M.(1);Laabidi, S.(1);Fekih, M.(1);Labidi, A.(1);Boubaker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P300: Predicting long-term outcome of ulcerative colitis using a validated histologic index of severity
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Mosli*, R. Bokhari, A. Noor, B. Alnahdi, M. Aldomyati, M. Alsahafi, H. Jawa, E. Aljahdli, Y. Qari

Created: Thursday, 21 February 2019, 9:14 AM
P300: Predictors of a second surgery in patients with Crohn’s disease: are we following the right path?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Raimundo Fernandes*, S. Bernardo, C. Baldaia, P. Moura Santos, A. Rita Gonçalves, A. Valente, L. Correia, J. Velosa

Created: Friday, 22 February 2019, 9:49 AM
P300: Very early onset Inflammatory Bowel Diseases: Review of the Genoa-Messina joint clinical experience. Therapeutic approach: Part II
Year: 2022
Source: ECCO'22
Authors: Gramaglia, S.M.C.(1);Cucinotta, U.(1);Dipasquale, V.(1);Serena, A.(2);Gandullia, P.(2);Romano, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P301 Agreement in histologic diagnosis of preneoplastic lesions in inflammatory bowel disease: Results from a national survey in Italy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Canavese1, L. Saragoni2, T. Salviato3, L. Reggiani Bonetti4, G. Leoncini5, L. Baron6, M. Facchetti7, C. Vignale1, V. Villanacci7

Created: Thursday, 30 January 2020, 10:12 AM
P301: A serological biomarker of type VIII collagen that contains the anti-angiogenic signalling molecule, vastatin, is associated with the extension of disease in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Lindholm*1,2, L. E. Godskesen2, L. L. Langholm1, J. Kjeldsen2, A. Krag2, M. A. Karsdal1, T. Manon-Jensen1, J. H. Mortensen1

Created: Friday, 22 February 2019, 9:41 AM
P301: Effects of telemonitoring on safety and health care costs with a web platform (TECCU) in complex IBD patients: A randomised controlled trial
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Aguas1,2,3, J. Del Hoyo1*, R. Faubel4,5, D. Muñoz1, D. Domínguez6, G. Bastida1,2, B. Navarro1, G. Cordon1, A. Barrios1, B. Valdivieso3,7, M. Correcher8, P. Nos1,2,3

Created: Thursday, 21 February 2019, 9:14 AM